Key Metrics

Market Cap
Total Shares Outstanding
Book Value
PE Ratio

PS Ratio
PB Ratio
Forward PE Ratio
ROIC

Return on Aseets
Return on Equity
Dividend
Dividend Yield

Balancesheet Metrics

Total Assets
Total Liability
Assets-to-Libability Ratio

Total Current Assets
Total Current Liability
Current Ratio

Quick Ratio
Debt to Equity Ratio

Income Statement Metrics

Net Income
EPS
EBITA

Gross Profit
Gross Profit Margin
Operating Margin

Net Profit Margin

Price Metrics

5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA

52 Weeks High
52 Weeks low
All Time High

RSI
MACD

Share Stats

Shares Float
Shares Short

% Short
% Insider

% Institutions

% Institutions

News

Profile

G Medical Innovations Holdings Ltd. Warrants (GMVDW)

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Exchange: NASDAQ

IPO Date: 6/25/2021

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 0

Address: 5 Oppenheimer Street, Rehovot, Israel, 7670105

https://gmedinnovations.com

Quarterly Yearly

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	03/31/2023	12/31/2022	09/30/2022	06/30/2022	03/31/2022	12/31/2021	06/30/2021	Totals
	03/31/2023	12/31/2022	09/30/2022	06/30/2022	03/31/2022	12/31/2021	06/30/2021	Totals
Assets	4.83K	4.83K	10.28K	10.28K	10.52K	10.52K	17.22K	68.46K
Current Assets	1.99K	1.99K	5.92K	5.92K	8.55K	8.55K	15.45K	48.37K
Cash And Short Term Investments	295	295	1.51K	1.51K	6.03K	6.03K	13.38K	29.06K
Net Receivables	944	944	1.90K	1.90K	985	985	1.39K	9.05K
Inventory	292	292	2.34K	2.34K	355	355	46	6.02K
Other Current Assets	462	462	171	171	1.18K	1.18K	629	4.25K
Non Current Assets	2.83K	2.83K	4.36K	4.36K	1.97K	1.97K	1.77K	20.09K
Non Currrent Assets Other	185	185	312	312	-4.49K	213	233	-3.05K
Liabilities	9.40K	9.40K	11.52K	11.52K	13.33K	13.33K	10.57K	79.06K
Current Liabilities	9.11K	9.11K	10.61K	10.61K	8.28K	8.28K	10.16K	66.18K
Accounts Payable	4.66K	4.66K	3.46K	3.46K	2.33K	2.33K	3.30K	24.19K
Short Long Term Debt	-	1.65K	-	831	-	2.67K	2.40K	7.55K
Other Current Liabilities	2.65K	2.65K	5.88K	5.88K	1.91K	3.15K	4.34K	26.46K
Non Current Liabilities	283	283	905	905	5.05K	5.05K	406	12.88K
Stockholder Equity	-7.35K	-7.35K	-4.19K	-4.19K	-6.03K	-6.03K	3.38K	-31.78K
Liabilities And Stockholders Equity	4.83K	4.83K	10.28K	10.28K	10.52K	10.52K	17.22K	68.46K
Totals		35.40K	37.04K	65.25K	66.08K	60.48K	69.10K	101.89K	435.24K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	Totals
	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	Totals
Assets	4.83K	10.52K	5.45K	8.77K	14.18K	21.50K	65.24K
Current Assets	1.99K	8.55K	3.13K	2.37K	7.63K	16.95K	40.64K
Cash And Short Term Investments	295	6.03K	278	717	-	-	7.32K
Net Receivables	944	985	1.29K	1.28K	705	140	5.34K
Inventory	292	355	90	378	1.35K	231	2.70K
Other Current Assets	462	1.18K	1.48K	-	1.25K	1.78K	6.15K
Non Current Assets	2.83K	1.97K	2.31K	6.40K	6.54K	4.55K	24.60K
Property Plant Equipment	-	-	-	-	-	-	-
Long Term Investments	-	-	-	-	-	-	-
Non Currrent Assets Other	185	-4.49K	-	71	242	-	-4.00K
Liabilities	9.40K	13.33K	8.40K	18.65K	16.77K	8.29K	74.83K
Current Liabilities	9.11K	8.28K	7.90K	17.10K	12.29K	4.54K	59.22K
Accounts Payable	4.66K	2.33K	4.07K	3.33K	2.39K	1.38K	18.15K
Short Long Term Debt	1.65K	2.67K	2.10K	8.70K	7.63K	2.16K	24.92K
Other Current Liabilities	2.65K	1.91K	359	4.71K	888	100	10.61K
Non Current Liabilities	283	5.05K	498	1.54K	4.48K	3.76K	15.61K
Long Term Debt	-	-	-	-	-	-	-
Other Liabilities	-	-	-	-	-	-	-
Stockholder Equity	-7.35K	-6.03K	-6.30K	-13.38K	-6.59K	8.50K	-31.15K
Preferred Stock Equity	-	-	-	-	-	-	-
Liabilities And Stockholders Equity	4.83K	10.52K	5.45K	8.77K	-	-	29.56K
Common Equity	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-
Totals		37.04K	63.15K	36.51K	69.41K	69.77K	73.88K	349.76K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	Totals
	Totals
Totals		-

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	Totals
	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	Totals
Revenue	5.06K	4.90K	5.53K	3.06K	109	18.66K
Cost Of Revenue	3.56K	4.23K	5.75K	4.03K	1.16K	18.72K
Gross Profit	1.50K	667	-223	-969	-1.05K	-69
Operating Expenses	15.10K	16.90K	18.31K	20.25K	26.63K	97.18K
Selling General Administrative	9.01K	7.66K	9.63K	13.27K	25.05K	64.63K
Research Development	1.68K	1.31K	619	243	244	4.10K
Other Operating Expenses	-	-	-	-	-	-
Operating Income	-10.04K	-12.00K	-12.78K	-17.18K	-26.52K	-78.53K
Net Interest Income	-3.62K	-406	-3.58K	-137	-641	-8.39K
Interest Income	870	344	263	858	282	2.62K
Interest Expense	4.49K	750	3.85K	995	923	11.01K
Other Income Expense Net	-1.23K	-296	-	-	-2.41K	-3.94K
Income Before Tax	-14.89K	-12.71K	-16.37K	-17.32K	-27.16K	-88.45K
Tax Provision	-3	-18	-857	-345	85	-1.14K
NetIncome	-14.89K	-12.69K	-15.01K	-16.98K	-27.06K	-86.62K
NetIncome Applicable To Common Shares	-	-	-	-	-	-
Ebit	-	-	-	-	-	-
Totals		-3.42K	-1.34K	-4.88K	-10.22K	-30.36K	-50.22K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	03/31/2022	06/30/2020	03/31/2020	12/31/2019	09/30/2019	Totals
	03/31/2022	06/30/2020	03/31/2020	12/31/2019	09/30/2019	Totals
Cash From Operating Activities	-11.49K	-	-	-	-	-11.49K
Net Income	-14.89K	-	-	-	-	-14.89K
Depreciation	1.36K	-	-	-	-	1.36K
Extraordinary Items	-	-	-	-	-	-
Change To Inventory	-265	-	-	-	-	-265
Capital Expenditures	-550	-	-	-	-	-550
Cash From Financing Activities	13.31K	2.57K	942	449	793	18.06K
Other Cashflows From Financing Activities	23.53K	1.74K	206	654	1.25K	27.39K
Totals		11.00K	4.31K	1.15K	1.10K	2.05K	19.61K

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	Totals
	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	Totals
Cash From Operating Activities	-18.48K	-11.49K	-4.65K	-	-	-	-34.62K
Net Income	-25.07K	-14.89K	-12.69K	-15.51K	-16.98K	-27.06K	-112.18K
Depreciation	1.21K	1.36K	1.42K	-	-	-	3.99K
Extraordinary Items	-	-	-	-	-	-	-
Change Receivables	-	-	-	-	-	-	-
Change To Inventory	-2.02K	-265	288	-	-	-	-2.00K
Change To Liabilities	-	-	-	-	-	-	-
Change To Net Income	-	-	-	-	-	-	-
ChangeToOperatingActivities	-	-	-	-	-	-	-
Cash flows From Investing Activities	-	-	-	-	-	-	-
Capital Expenditures	-2.12K	-550	-507	-429	-2.37K	-1.49K	-7.46K
Other Cashflows From Investing Activities	-	-	-	-	-	-	-
Cash From Financing Activities	14.86K	17.27K	5.38K	4.10K	8.85K	23.13K	73.59K
Net Borrowings	-	-	-	-	-	-	-
Sale Purchase Of Stock	-121	-	-	-	-	-	-121
Dividends Paid	-	-	-	-	-	-	-
Other Cashflows From Financing Activities	17.85K	5.84K	1.37K	5.88K	-	-	30.94K
Cash And Cash Equivalents Changes	-	-	-	-	-	-	-
Totals		-13.88K	-2.73K	-9.39K	-5.95K	-10.49K	-5.42K	-47.86K

Profile

Free Stocks

Company

Features

Contact Us